other

Updated:

Rentokil Steritech

Rentokil Steritech is a pest control services subsidiary of FTSE 100 Rentokil Initial, generating over $2B in annual revenue across North America.

Rentokil Steritech

Rentokil Steritech is a subsidiary of Rentokil North America, listed on the OTCMKTS as RKLIF. It operates in the U.S. and Canada, offering commercial and residential pest control services through its team of trained technicians. The company also owns regional brands Western Exterminator, Presto-X Pest Control, and Ehrlich Pest Control.

General information

Firm type

other

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

United Kingdom

City

Camberley

Corporate office

Camberley, United Kingdom

Frequently asked questions

Is Rentokil Steritech a family office or investment firm?

No. Rentokil Steritech is an operating subsidiary of Rentokil Initial plc, a publicly traded hygiene and pest control company. It does not manage third-party capital or family wealth.

How is Rentokil Steritech structured within the parent company?

Rentokil Steritech functions as the North American pest control division of Rentokil Initial plc. The parent company reports financials publicly via London Stock Exchange filings.

Does Rentokil Steritech make direct investments or acquisitions?

Acquisitions are executed by the parent company, Rentokil Initial. Rentokil Steritech itself operates service branches rather than deploying investment capital.

What is the revenue or AUM of Rentokil Steritech?

As a subsidiary, no AUM is reported. Rentokil Initial's Americas region, which includes Rentokil Steritech, reported 2024 revenue of approximately £1.8 billion (per Rentokil Initial annual report, 2024).

Where does the underlying wealth or capital come from?

Rentokil Initial is a publicly traded company, so capital comes from public equity and debt markets, not from a single family's wealth.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Camberley other profiles